Projects funded by the NCN
Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic Alzheimer's Disease
2020/39/B/NZ7/00974
Keywords:
Alzheimer's disease neurodegeneration neuroprotection estrogen receptors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_5: Molecular neurobiology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 20 - announced on 2020-09-15
Amount awarded: 1 451 800 PLN
Project start date (Y-m-d): 2021-07-27
Project end date (Y-m-d): 2024-07-26
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.